tiprankstipranks
Advertisement
Advertisement

HK:2696 Stock Latest News

Shanghai Henlius Biotech Sets August Board Meeting to Approve Interim Results
Company AnnouncementsShanghai Henlius Biotech Sets August Board Meeting to Approve Interim Results
2d ago
2696
Henlius Wins NMPA Nod to Start New HLX43 Combination Trials in China
PremiumCompany Announcements
Henlius Wins NMPA Nod to Start New HLX43 Combination Trials in China
5d ago
2696
Henlius Starts First-in-Human Trial of Novel Trispecific Prostate Cancer Antibody
PremiumCompany Announcements
Henlius Starts First-in-Human Trial of Novel Trispecific Prostate Cancer Antibody
6d ago
2696
Shanghai Henlius Biotech Grants New Share Options and RSUs to Strengthen Incentives
PremiumCompany Announcements
Shanghai Henlius Biotech Grants New Share Options and RSUs to Strengthen Incentives
18d ago
2696
Henlius Doses First Patient in Global Trial of Nivolumab Biosimilar HLX18
PremiumCompany Announcements
Henlius Doses First Patient in Global Trial of Nivolumab Biosimilar HLX18
20d ago
2696
Henlius Wins NMPA Nod for HLX37 and HLX43 Combination Trial in Advanced Solid Tumours
PremiumCompany AnnouncementsHenlius Wins NMPA Nod for HLX37 and HLX43 Combination Trial in Advanced Solid Tumours
26d ago
2696
Henlius Doses First Patient in Phase 1 Trial for Cetuximab Biosimilar HLX05-N
Premium
Company Announcements
Henlius Doses First Patient in Phase 1 Trial for Cetuximab Biosimilar HLX05-N
28d ago
2696
Henlius Starts First-in-Human Trial of Novel Dual-Target Cancer ADC HLX48
Premium
Company Announcements
Henlius Starts First-in-Human Trial of Novel Dual-Target Cancer ADC HLX48
1M ago
2696
Henlius Doses First U.S. Patient in Global Trial of Ipilimumab Biosimilar HLX13
PremiumCompany Announcements
Henlius Doses First U.S. Patient in Global Trial of Ipilimumab Biosimilar HLX13
1M ago
2696
Henlius wins EU nod for new lung cancer use of serplulimab
PremiumCompany Announcements
Henlius wins EU nod for new lung cancer use of serplulimab
1M ago
2696
Henlius Wins GMP Green Light for HANBEIYOU Production in Mainland China
PremiumCompany Announcements
Henlius Wins GMP Green Light for HANBEIYOU Production in Mainland China
2M ago
2696
Henlius Wins NMPA Nod for First-in-Class Trispecific Prostate Cancer Therapy Trial
PremiumCompany Announcements
Henlius Wins NMPA Nod for First-in-Class Trispecific Prostate Cancer Therapy Trial
2M ago
2696
Henlius Wins Australian Nod for Phase 2 NSCLC Trial of HLX43 Combo
PremiumCompany AnnouncementsHenlius Wins Australian Nod for Phase 2 NSCLC Trial of HLX43 Combo
2M ago
2696
Henlius Phase 3 Eye Drug HLX04-O Hits Key Goals in Global wAMD Trial
Premium
Company Announcements
Henlius Phase 3 Eye Drug HLX04-O Hits Key Goals in Global wAMD Trial
2M ago
2696
Henlius Wins China Approval for New Gastric Cancer Use of HANSIZHUANG
Premium
Company Announcements
Henlius Wins China Approval for New Gastric Cancer Use of HANSIZHUANG
2M ago
2696
Henlius Starts Global Phase 1 Trial of Pembrolizumab Biosimilar HLX17 in U.S. and China
PremiumCompany Announcements
Henlius Starts Global Phase 1 Trial of Pembrolizumab Biosimilar HLX17 in U.S. and China
2M ago
2696
Henlius Wins China Approval for HANBEIYOU Breast Cancer Biosimilar
PremiumCompany Announcements
Henlius Wins China Approval for HANBEIYOU Breast Cancer Biosimilar
2M ago
2696
Henlius Starts Global Phase 2/3 Trial of ADC HLX43 in Advanced Lung Cancer
PremiumCompany Announcements
Henlius Starts Global Phase 2/3 Trial of ADC HLX43 in Advanced Lung Cancer
2M ago
2696
Henlius Starts First-Patient Dosing in Phase 1 Study of Daratumumab Biosimilar HLX15-SC for Newly Diagnosed Multiple Myeloma
PremiumCompany Announcements
Henlius Starts First-Patient Dosing in Phase 1 Study of Daratumumab Biosimilar HLX15-SC for Newly Diagnosed Multiple Myeloma
2M ago
2696
Henlius doses first patient in pivotal HLX07–serplulimab lung cancer trial in China
PremiumCompany AnnouncementsHenlius doses first patient in pivotal HLX07–serplulimab lung cancer trial in China
2M ago
2696
Henlius Wins Key EMA Backing for Serplulimab Lung Cancer Use
Premium
Company Announcements
Henlius Wins Key EMA Backing for Serplulimab Lung Cancer Use
2M ago
2696
Henlius Begins First-in-Human Trial of First-in-Class B7-H3 Cancer Fusion Protein
Premium
Company Announcements
Henlius Begins First-in-Human Trial of First-in-Class B7-H3 Cancer Fusion Protein
2M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >